American Society of Clinical Oncology 2021 Podcast: HR+, HER2- Breast Cancer.
作者信息
Cheung Kwok-Leung
机构信息
University of Nottingham, Nottingham, UK.
出版信息
Oncol Ther. 2021 Dec;9(2):267-272. doi: 10.1007/s40487-021-00164-2. Epub 2021 Aug 7.
Abstract
摘要
相似文献
1
American Society of Clinical Oncology 2021 Podcast: HR+, HER2- Breast Cancer.
Oncol Ther. 2021 Dec;9(2):267-272. doi: 10.1007/s40487-021-00164-2. Epub 2021 Aug 7.
2
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.
3
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Arch Pathol Lab Med. 2018 Nov;142(11):1364-1382. doi: 10.5858/arpa.2018-0902-SA. Epub 2018 May 30.
4
Defining breast cancer intrinsic subtypes by quantitative receptor expression.
Oncologist. 2015 May;20(5):474-82. doi: 10.1634/theoncologist.2014-0372. Epub 2015 Apr 23.
5
Comparative Analysis of Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer According to 2007 and 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations.
J Clin Oncol. 2017 Sep 10;35(26):3039-3045. doi: 10.1200/JCO.2016.70.5319. Epub 2017 Apr 26.
6
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
J Clin Oncol. 2018 Jul 10;36(20):2105-2122. doi: 10.1200/JCO.2018.77.8738. Epub 2018 May 30.
7
Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer.
Cancer. 2017 Jun 15;123(12):2230-2239. doi: 10.1002/cncr.30592. Epub 2017 Feb 13.
8
Clinical and Pathologic Features Associated With Invasive Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists In Situ Hybridization Group 2 Results (Human Epidermal Growth Factor Receptor 2 [HER2]/Chromosome 17 Centromere [CEP17] Ratio ≥2.0 and Average HER2 Copy Number <4.0).
Arch Pathol Lab Med. 2022 Jun 1;146(6):701-709. doi: 10.5858/arpa.2021-0155-OA.
9
Highlights in breast cancer from ASCO 2016.
ESMO Open. 2016 Oct 26;1(5):e000106. doi: 10.1136/esmoopen-2016-000106. eCollection 2016.
10
Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With /CEP17 Ratio <2.0 and Average Copy Number ≥4.0 and <6.0.
Arch Pathol Lab Med. 2020 May;144(5):597-601. doi: 10.5858/arpa.2019-0307-OA. Epub 2019 Oct 24.
本文引用的文献
1
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial.
J Clin Oncol. 2024 Oct 20;42(30):3561-3569. doi: 10.1200/JCO.23.01995. Epub 2024 Jul 24.
2
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B.
ESMO Open. 2024 Jun;9(6):103466. doi: 10.1016/j.esmoop.2024.103466. Epub 2024 Jun 4.
3
Current Challenges Faced by Cancer Clinical Trials in Addressing the Problem of Under-Representation of Older Adults: A Narrative Review.
Oncol Ther. 2021 Jun;9(1):55-67. doi: 10.1007/s40487-021-00140-w. Epub 2021 Jan 22.
4
Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative.
Lancet Oncol. 2021 Jan;22(1):e29-e36. doi: 10.1016/S1470-2045(20)30473-3.
Zotero 插件